Skip to content

Clinical trials

Phase 1/2 Carcinoma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 1/2 Country / region: Spain Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20172
20181
20191
20201
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company1
Hoffmann-La Roche1
Hookipa Biotech GmbH1
Marengo Therapeutics, Inc.1
MedImmune LLC1
Numab Therapeutics AG1
Pfizer1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma8
Carcinoma, Non-Small-Cell Lung5
Head and Neck Neoplasms4
Neoplasms4
Colorectal Neoplasms3
Gastrointestinal Neoplasms3
Lung Neoplasms3
Neoplasms by Site3
Adenocarcinoma2
Bronchial Neoplasms2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.